# of Displayed Technologies: 6 / 6


Custom Design for DNA Methylation Microarray to Assess the Long-Term Health Risks Associated with Nutritional Stress
TS-005787 — This custom DNA methylation microarray is designed to assess long‑term health risks and recovery potential associated with early‑life nutritional stress and starvation, based on the discovery of unique DNA methylation signatures that distinguish individuals who survived severe childhood starvation and achieved advanced age (70–80 years).
  • College:
  • Inventors: Artomov, Mykyta
  • Licensing Officer: Corris, Andrew

Using Skin Patches with DNA-Methylation-Guided Dosage of Ghrelin and Leptin to Treat Anorexia Nervosa
TS-005784 — This novel, personalized hormone‑replacement therapy for anorexia nervosa (AN) simultaneously targets dysregulated ghrelin and leptin signaling using a transdermal skin‑patch delivery system. This represents a new device and treatment paradigm for AN, introducing both a previously undescribed hormone combination therapy and a precision‑medicine framework that tailors treatment based on epigenetic biomarkers, with strong translational potential supported by an existing, genomically characterized patient cohort.
  • College:
  • Inventors: Artomov, Mykyta
  • Licensing Officer: Corris, Andrew

LES: Fast Genomic Reporting Tool
TS-005666 — This new IP is an algorithm and data-storage framework designed to improve how large‑scale genetic datasets are stored, queried, and analyzed. By reorganizing genetic information into fixed groups, this eliminates the need to retain sensitive individual‑level data, reduces storage requirements, and enables rapid, on‑demand estimation of allele frequencies across datasets.
  • College:
  • Inventors: Artomov, Mykyta
  • Licensing Officer: Corris, Andrew

Genetic Testing for Assessment of Skin Cancer Risk in Patients with Hypothyroidism
TS-005489 — This technique for genetic testing uses polygenic risk scores as a measure of susceptibility to skin cancers for individuals with hypothyroidism. Diagnosis of hypothyroidism has been correlated with increased risk of skin cancer, while genetic susceptibility to hypothyroidism has been correlated with decreased risk of skin cancer. Using polygenic testing, subjects with top 10% polygenic risk scores have neutral to decreased risk, while subjects with bottom 10% scores have elevated risks of skin cancer.
  • College:
  • Inventors: Molotkov, Ivan; Artomov, Mykyta
  • Licensing Officer: Corris, Andrew

An Analytical Platform for Personalized Multi-Factor Genetic Risk Stratification and Disease Risk Prediction
TS-004605 — The polygenic scores (PGS) browser, a web-based application, improves precision medicine and calculates an individual’s genetic risk, providing access to over 3,000 PGS models and 10,000 studies.
  • College:
  • Inventors: Kolosov, Nikita; Artomov, Mykyta
  • Licensing Officer: Corris, Andrew

An Analytical Platform for Personalized Multi-Factor Genetic Risk Stratification and Disease Risk Prediction
TS-004604 — The polygenic scores (PGS) browser is a web-based application designed to improve precision medicine and calculate an individual’s genetic risk. The application provides users with access to a comprehensive and well-annotated database with over 3,000 PGS models. Users may select the most suita…
  • College:
  • Inventors: Kolosov, Nikita; Artomov, Mykyta
  • Licensing Officer: Corris, Andrew

Loading icon